INTEGRA LIFESCIENCES HOLDINGS CORP ·
IART 8-K 2026-10-02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) 8-K dated 2026-10-02 — accession 0000917520-26-000067. This URL is the filing, not the IART hub.
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is a medical devices company listed on US.
IART: SECURITIES AND EXCHANGE COMMISSION
Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. IART currently screens at market cap $1.32B.
Not investment advice. The IART SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects its reported revenue to be between $410 million to $412 million, reflecting an estimated $7 million impact of flooding-
Why it matters
- expects its reported revenue to be between $410 million to $412 million, reflecting an estimated $7 million impact of flooding-